Commission Implementing Regulation (EU) 2018/112Show full title

Commission Implementing Regulation (EU) 2018/112 of 24 January 2018 renewing the approval of the low-risk active substance laminarin in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (Text with EEA relevance)

ANNEX I

a

Further details on identity and specification of active substance are provided in the renewal report.

Common Name, Identification NumbersIUPAC NamePurityaDate of approvalExpiration of approvalSpecific provisions

Laminarin

CAS No 9008-22-4

CIPAC No 671

(1→3)-β-D-glucan

(according to IUPAC-IUB Joint Commission on Biochemical Nomenclature)

≥ 860 g/kg on dry matter (TC)1 March 201828 February 2033

For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on laminarin, and in particular Appendices I and II thereto, shall be taken into account.

Conditions of use shall include risk mitigation measures, where appropriate.

ANNEX II

The Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

(1)

in Part A, the entry 95 on laminarin is deleted;

(2)

in Part D, the following entry is added:

a

Further details on identity and specification of active substance are provided in the renewal report.

NumberCommon Name, Identification NumbersIUPAC NamePurityaDate of approvalExpiration of approvalSpecific provisions
‘12

Laminarin

CAS No 9008-22-4

CIPAC No 671

(1→3)-β-D-glucan

(according to IUPAC-IUB Joint Commission on Biochemical Nomenclature)

≥ 860 g/kg on dry matter (TC)1 March 201828 February 2033

For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on laminarin, and in particular Appendices I and II thereto, shall be taken into account.

Conditions of use shall include risk mitigation measures, where appropriate.’